Correlation Between GM and CytomX Therapeutics
Can any of the company-specific risk be diversified away by investing in both GM and CytomX Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GM and CytomX Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between General Motors and CytomX Therapeutics, you can compare the effects of market volatilities on GM and CytomX Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GM with a short position of CytomX Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of GM and CytomX Therapeutics.
Diversification Opportunities for GM and CytomX Therapeutics
-0.81 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between GM and CytomX is -0.81. Overlapping area represents the amount of risk that can be diversified away by holding General Motors and CytomX Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on CytomX Therapeutics and GM is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on General Motors are associated (or correlated) with CytomX Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of CytomX Therapeutics has no effect on the direction of GM i.e., GM and CytomX Therapeutics go up and down completely randomly.
Pair Corralation between GM and CytomX Therapeutics
Allowing for the 90-day total investment horizon General Motors is expected to generate 0.6 times more return on investment than CytomX Therapeutics. However, General Motors is 1.66 times less risky than CytomX Therapeutics. It trades about 0.11 of its potential returns per unit of risk. CytomX Therapeutics is currently generating about -0.14 per unit of risk. If you would invest 4,287 in General Motors on August 24, 2024 and sell it today you would earn a total of 1,281 from holding General Motors or generate 29.88% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Against |
| Strength | Significant |
| Accuracy | 99.21% |
| Values | Daily Returns |
General Motors vs. CytomX Therapeutics
Performance |
| Timeline |
| General Motors |
| CytomX Therapeutics |
GM and CytomX Therapeutics Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with GM and CytomX Therapeutics
The main advantage of trading using opposite GM and CytomX Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GM position performs unexpectedly, CytomX Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in CytomX Therapeutics will offset losses from the drop in CytomX Therapeutics' long position.The idea behind General Motors and CytomX Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.| CytomX Therapeutics vs. ZyVersa Therapeutics | CytomX Therapeutics vs. Sonnet Biotherapeutics Holdings | CytomX Therapeutics vs. Zura Bio Limited | CytomX Therapeutics vs. Phio Pharmaceuticals Corp |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Suggestion module to get suggestions outside of your existing asset allocation including your own model portfolios.
Other Complementary Tools
| Equity Forecasting Use basic forecasting models to generate price predictions and determine price momentum | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Commodity Directory Find actively traded commodities issued by global exchanges | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk | |
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences |